Results | SCSU Bibliography

McEwen, B. B. (2004). De Wied and colleagues I: evidence for a VP and an OT influence on MP: launching the “VP/OT central memory theory”. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 51–708. https://doi.org/10/cqnrtn

McEwen, B. B. (2004). De Wied and colleagues II: further clarification of the roles of vasopressin and oxytocin in memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 103–708. https://doi.org/10/bnwdmj

McEwen, B. B. (2004). De Wied and colleagues III: brain sites and transmitter systems involved in the vasopressin and oxytocin influence on memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 141–708. https://doi.org/10/bs36s7

McEwen, B. B. (2004). De Wied and colleagues IV: research into mechanisms of action by which vasopressin and oxytocin influence memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 177–708. https://doi.org/10/dkps7w

McEwen, B. B. (2004). General introduction to vasopressin and oxytocin: structure/metabolism, evolutionary aspects, neural pathway/receptor distribution, and functional aspects relevant to memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 1–708. https://doi.org/10/cb26sb

McEwen, B. B. (2004). Research studies of Koob and colleagues: the “vasopressin dual action theory”. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 227–708. https://doi.org/10/cw932k

Wilder, N., Gilders, R., Hagerman, F., & Deivert, R. G. (2002). The effects of a 10-week, periodized, off-season resistance-training program and creatine supplementation among collegiate football players. Journal of Strength and Conditioning Research, 16(3), 343–352. https://doi.org/10.1519/1533-4287(2002)016%3C0343:TEOAWP%3E2.0.CO;2

The periodized resistance-training model has not been well documented in the literature. Further research is needed to determine if periodized resistance training in conjunction with creatine supplementation can cause changes in strength, performance, total body weight, girth, and lean muscle mass. Therefore, the purpose of this investigation was to determine the effects of periodized resistance training in conjunction with low-dose (LD) and high-dose (HD) creatine supplementation on strength, body composition, and anaerobic muscular endurance. Subjects were divided into 3 groups: LD, HD, and placebo (P). Testing took place pre-, mid-, and postsupplementation for the following: weight, body composition (fat-free mass and fat mass), 1 repetition maximum squat, and anaerobic muscular endurance testing. Results revealed no significant differences in either creatine group when compared with the P group. However, significant differences were noted over time. These data suggest that 10 weeks of periodized resistance training was effective for causing changes in strength, body composition, and anaerobic muscular endurance.

View on dx.doi.org

Jirsa, R. E. (2001). Maximum length sequences-auditory brainstem responses from children with auditory processing disorders. Journal of the American Academy of Audiology, 12(3), 155–164. Scopus. https://doi.org/10.1055/s-0042-1745592

This study was designed to evaluate maximum length sequences-auditory brainstem responses (MLS-ABR) in children with auditory processing disorders and to compare these results with a normal control group matched for age, intelligence, and gender. Although each waveform was analyzed for the presence of waves I, III, and V, the primary focus was wave V. Although absolute latency measures for wave V were obtained from all subjects, waves I and III were not always identified. Although the results showed latency increases for all waveforms in both groups, the only significant difference noted was an increase in wave V latency for both the left and right ears in the clinical group. These results suggest that the MLS-ABR may be useful in the assessment of auditory processing disorders. Implications for the potential use of the MLS-ABR in management programs are discussed.

View on www.scopus.com

Nobert, G. S., Kraak, M. M., & Crawford, S. (2006). Estrogen dependent growth inhibitory effects of tamoxifen but not genistein in solid tumors derived from estrogen receptor positive (ER+) primary breast carcinoma MCF7: single agent and novel combined treatment approaches. Bulletin Du Cancer, 93(7), E59-66.

While many studies have documented tamoxifen's benefits as an adjuvant therapy in the treatment and prevention of recurrent breast cancer in estrogen receptor positive (ER+) breast carcinoma, this beneficial effect may decrease with long-term tamoxifen use. This experimental study was designed to compare the cytotoxic responses of ER+ primary breast cancer solid tumors derived from the MCF7 cell line to experimental therapeutics, including genistein, tamoxifen, all-trans retinoic acid (ATRA) and parthenolide in the presence and absence of exogenous beta-estradiol. The results of this study suggest that the growth inhibitory effects of tamoxifen, were dependent on beta-estradiol levels. In contrast, the cytotoxic effects of the isoflavone soy derivative, genistein, were observed to be independent of exogenous estrogen. Moreover, combined therapy using tamoxifen and genistein produced enhanced cytotoxic effects also independent of beta-estradiol levels. Additional studies involving the use of the novel agents all trans retinoic acid (ATRA) and parthenolide produced notable tumor responses and combined effects that were also estrogen-independent. Overall, these preclinical research findings suggest possible clinical applications suggesting that genistein might be a useful clinical adjuvant, particularly in post-menopausal women in whom breast cancer occurs more frequently. Moreover, this research suggests that combined treatment approaches involving the use of tamoxifen in conjunction with agents that inhibit NFkappaB pathway signaling, such as parthenolide and genistein, warrant further study.

McEwen, B. B. (2004). Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 531–708. https://doi.org/10/dv9xsc

McEwen, B. B. (2004). Closing remarks: review and commentary on selected aspects of the roles of vasopressin and oxytocin in memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 593–708. https://doi.org/10/cnvfjm

McEwen, B. B. (2004). Expansion of olfactory-based social recognition memory research: the roles of vasopressin and oxytocin in social recognition memory. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 475–708. https://doi.org/10/d2pg8g

McEwen, B. B. (2004). Expansion of vasopressin/oxytocin memory research I: peripheral administration. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 339–708. https://doi.org/10/bkwxbk

McEwen, B. B. (2004). Expansion of vasopressin/oxytocin memory research II: brain structures and transmitter systems involved in the influence of vasopressin and oxytocin on memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 389–708. https://doi.org/10/bqqxkh

McEwen, B. B. (2004). Expansion of vasopressin/oxytocin memory research III: research summary and commentary on theoretical and methodological issues. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 421–708. https://doi.org/10/fhz3dx

McEwen, B. B. (2004). Research contributions of Dantzer, Bluthe, and colleagues to the study of the role of vasopressin in olfactory-based social recognition memory. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 453–708. https://doi.org/10/bcrt8g

McEwen, B. B. (2004). Role of attentional processing in mediating the influence of vasopressin on memory processing. Advances in Pharmacology (San Diego, Calif.), 50(axi, 9015397), 295–708. https://doi.org/10/bg3vpv

Lunn, W. R., Finn, J. A., & Axtell, R. S. (2009). Effects of sprint interval training and body weight reduction on power to weight ratio in experienced cyclists. Journal of Strength and Conditioning Research, 23(4), 1217–1224. https://doi.org/10/d7t698

The purpose of this study was to determine the effect of supramaximal sprint interval training (SIT), body weight reduction, and a combination of both treatments on peak and average anaerobic power to weight ratio (PPOan:Wt, APOan:Wt) by manipulating peak and average anaerobic power output (PPOan, APOan) and body weight (BW) in experienced cyclists. Participants (N = 34, age = 38.0 +/- 7.1 years) were assigned to 4 groups for a 10-week study. One group performed twice-weekly SIT sessions on a cycle ergometer while maintaining body weight (SIT). A second group did not perform SIT but intentionally reduced body weight (WR). A third group simultaneously performed SIT sessions and reduced body weight (SIT+WR). A control group cycled in their normal routine and maintained body weight (CON). The 30-second Wingate Test assessed pretest and posttest POan:Wt scores. There was a significant mean increase (p < 0.05) from pretest to posttest in PPOan:Wt and APOan:Wt (W x kg(-1)) scores in both SIT (10.82 +/- 1.71 to 11.92 +/- 1.77 and 8.05 +/- 0.64 to 8.77 +/- 0.64, respectively) and WR (10.33 +/- 2.91 to 11.29 +/- 2.80 and 7.04 +/- 1.45 to 7.62 +/- 1.24, respectively). PPOan and APOan (W) increased significantly only in SIT (753.7 +/- 121.0 to 834.3 +/- 150.1 and 561.3 +/- 62.5 to 612.7 +/- 69.0, respectively). Body weight (kg) decreased significantly in WR and SIT + WR (80.3 +/- 13.7 to 75.3 +/- 11.9 and 78.9 +/- 10.8 to 73.4 +/- 10.8, respectively). The results demonstrate that cyclists can use SIT sessions and body weight reduction as singular training interventions to effect significant increases in anaerobic power to weight ratio, which has been correlated to enhanced aerobic cycling performance. However, the treatments were not effective as combined interventions, as there was no significant change in either PPOan:Wt or APOan:Wt in SIT + WR.

Shipley, V. (2009). Reflections: neurology and the humanities. You had the choice, Martha. Neurology, 72(12), 1106. https://doi.org/10/fm3cp9

Phelps, S., & Doering, G. (2008). The performance-level model of hospital decontamination preparedness. American Journal of Disaster Medicine, 3(3), 157–163. https://doi.org/10/gmvm57

OBJECTIVE: Describe a multilevel model of decontamination capacity for hospitals., DESIGN: Descriptive model., SETTING: Acute care hospitals with decontamination responsibilities., PATIENTS, PARTICIPANTS: None., INTERVENTIONS: None., MAIN OUTCOME MEASURE(S): None., RESULTS: This multilevel model of defining decontamination capacity would allow more realistic assessment of current capacity, allow for fluctuating service levels depending on time of day, incorporate realistic ramp-up and ramp-down of decontamination services, allow for a defined fall-back decontamination model should decontamination processes fail, allow hospitals to define long-term decontamination service level goals, and allow better understanding of when and why to focus on low-risk/low-resource patients rather than high-risk/high-resource patients., CONCLUSIONS: This multiple-level model would allow for more realistic and effective hospital-based decontamination service models and should become part of the national decontamination paradigm.

Your search

Results 5,343 resources

Explore

Department

Resource type

Publication year

Resource language